# Pulmonary Vein Isolation Alone or in Combination With Substrate Modulation After Electric Cardioversion Failure

> **NCT05264831** · NA · RECRUITING · sponsor: **Elsan** · enrollment: 450 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Pulmonary Vein Isolation (PVI) alone
- **PROCEDURE:** PVI procedure associated with substrate modulation

## Key facts

- **NCT ID:** NCT05264831
- **Lead sponsor:** Elsan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-20
- **Primary completion:** 2025-04-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05264831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05264831, "Pulmonary Vein Isolation Alone or in Combination With Substrate Modulation After Electric Cardioversion Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05264831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*